Patents by Inventor Joel H. Collier

Joel H. Collier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS COMPRISING SELF-ASSEMBLING PEPTIDE-POLYMER NANOFIBERS FOR SUBLINGUAL IMMUNIZATION
    Publication number: 20220387605
    Abstract: Disclosed herein are peptide-polymer conjugates for the delivery of peptide epitopes sublingually to elicit an immune response.
    Type: Application
    Filed: July 18, 2018
    Publication date: December 8, 2022
    Inventors: Joel H. Collier, Sean H. Kelly
  • Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform
    Patent number: 11246924
    Abstract: Embodiments are directed to fibrillar adjuvants. Epitopes assembled into nanofibers by a short synthetic fibrillization domain elicited high antibody titers in the absence of any adjuvant.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: February 15, 2022
    Assignees: Duke University, Emory University
    Inventors: Joel H. Collier, Yaoying Wu, Vincent P. Conticello
  • ALPHA-HELICAL PEPTIDE NANOFIBERS AS A SELF-ADJUVANTING VACCINE PLATFORM
    Publication number: 20200390882
    Abstract: Embodiments are directed to fibrillar adjuvants. Epitopes assembled into nanofibers by a short synthetic fibrillization domain elicited high antibody titers in the absence of any adjuvant.
    Type: Application
    Filed: March 31, 2017
    Publication date: December 17, 2020
    Inventors: Joel H. Collier, Yaoying Wu, Vincent P. Conticello
  • Methods and compositions related to immunogenic fibrils
    Patent number: 10596238
    Abstract: Embodiments of the invention are directed to fibrillar adjuvants. Epitopes assembled into nanofibers by a short synthetic fibrillization domain elicited high antibody titers in the absence of any adjuvant.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: March 24, 2020
    Assignee: The University of Chicago
    Inventors: Joel H. Collier, Jai Simha Rudra
  • Methods and compositions related to immunogenic fibrils
    Patent number: 9849174
    Abstract: Embodiments of the invention are directed to fibrillar adjuvants. Epitopes assembled into nanofibers by a short synthetic fibrillization domain elicited high antibody titers in the absence of any adjuvant.
    Type: Grant
    Filed: September 25, 2015
    Date of Patent: December 26, 2017
    Assignees: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM, THE UNIVERSITY OF CHICAGO
    Inventors: Joel H. Collier, Jai S Rudra
  • METHODS AND COMPOSITIONS RELATED TO IMMUNOGENIC FIBRILS
    Publication number: 20160151507
    Abstract: Embodiments of the invention are directed to fibrillar adjuvants. Epitopes assembled into nanofibers by a short synthetic fibrillization domain elicited high antibody titers in the absence of any adjuvant.
    Type: Application
    Filed: December 18, 2015
    Publication date: June 2, 2016
    Inventors: Joel H. Collier, Jai Simha Rudra
  • METHODS AND COMPOSITIONS RELATED TO IMMUNOGENIC FIBRILS
    Publication number: 20160074509
    Abstract: Embodiments of the invention are directed to fibrillar adjuvants. Epitopes assembled into nanofibers by a short synthetic fibrillization domain elicited high antibody titers in the absence of any adjuvant.
    Type: Application
    Filed: September 25, 2015
    Publication date: March 17, 2016
    Inventors: JOEL H. COLLIER, Jai S Rudra
  • Methods and compositions related to immunogenic fibrils
    Patent number: 9241987
    Abstract: Embodiments of the invention are directed to fibrillar adjuvants. Epitopes assembled into nanofibers by a short synthetic fibrillization domain elicited high antibody titers in the absence of any adjuvant.
    Type: Grant
    Filed: November 19, 2010
    Date of Patent: January 26, 2016
    Assignee: The University of Chicago
    Inventors: Joel H. Collier, Jai Simha Rudra
  • METHODS AND COMPOSITIONS RELATED TO IMMUNOGENIC FIBRILS
    Publication number: 20120282292
    Abstract: Embodiments of the invention are directed to fibrillar adjuvants. Epitopes assembled into nanofibers by a short synthetic fibrillization domain elicited high antibody titers in the absence of any adjuvant.
    Type: Application
    Filed: November 19, 2010
    Publication date: November 8, 2012
    Applicant: University of Chicago
    Inventors: Joel H. Collier, Jai Simha Rudra